TW201818279A - Method of detecting blood supply abnormality of ventricle by measuring arterial pulse wave - Google Patents
Method of detecting blood supply abnormality of ventricle by measuring arterial pulse wave Download PDFInfo
- Publication number
- TW201818279A TW201818279A TW105136506A TW105136506A TW201818279A TW 201818279 A TW201818279 A TW 201818279A TW 105136506 A TW105136506 A TW 105136506A TW 105136506 A TW105136506 A TW 105136506A TW 201818279 A TW201818279 A TW 201818279A
- Authority
- TW
- Taiwan
- Prior art keywords
- value
- blood supply
- time series
- series signal
- pulse time
- Prior art date
Links
Landscapes
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
Description
本發明係有關於一種量測心臟血流脈波以檢測心室供血異常之方法,尤其係指一種輔助檢查心血管疾病的測量方法,旨在將血壓計所量測的心血管供血脈波經過轉換成對應之特定代表數值,而能快速檢測受測個體是否存在心室供血異常等心血管疾病。The invention relates to a method for measuring blood flow pulse of a heart to detect abnormal blood supply to the ventricle, in particular to a method for assisting the examination of cardiovascular diseases, which aims to convert the blood supply pulse of the cardiovascular blood pressure measured by the sphygmomanometer Corresponding to the specific representative value, it can quickly detect whether the test subject has cardiovascular disease such as abnormal ventricular blood supply.
按,心血管疾病(cardiovascular disease)又稱為循環系統疾病,主要係涉及心臟或血管相關之疾病。常見的心血管疾病包括冠狀動脈症(Coronary artery disease)、高血壓性心臟病、中風、心律不整(cardiac arrhythmia)等等。冠狀動脈症係由於冠狀動脈內有阻塞情形(如膽固醇的堆積)而心臟的供血量,若係部份阻塞稱為狹心症,若是完全阻塞,導致心臟的供血阻斷則可能為心肌梗塞。心律不整係指心臟電傳導系統失常而引起的心跳不規則(過快或過慢)。由於輕微的心律不整並無明顯無症狀,因此許多患者無法輕易警覺本身是否罹患心律不整,容易造成病況持續惡化而並發展其它威脅生命的併發症,如心跳驟停、休克、猝死等等。According to the cardiovascular disease, also known as circulatory diseases, mainly related to heart or blood vessel related diseases. Common cardiovascular diseases include Coronary artery disease, hypertensive heart disease, stroke, cardiac arrhythmia, and the like. Coronary artery disease is the blood supply to the heart due to obstruction in the coronary arteries (such as accumulation of cholesterol). If the partial obstruction is called angina, if it is completely blocked, the blood supply to the heart may be blocked. . Arrhythmia refers to irregular heartbeat (too fast or too slow) caused by abnormalities in the cardiac conduction system. Because mild arrhythmia is not clearly asymptomatic, many patients are not easily aware of whether they have arrhythmia, which can easily lead to continued deterioration of the condition and develop other life-threatening complications such as cardiac arrest, shock, sudden death, and so on.
心臟包括兩個心房和兩個心室(Ventricle),其中左心室會接收來自左心房的動脈血,再由主動脈將血液供應至全身。正常情況下,左心室之心肌可在每次收縮後瞬速放鬆,使來自肺靜脈的血液快速地填充,此即心臟舒張期的放鬆與填充;並可迅速的激烈收縮以推動大量的血液進入大動脈並運送至身體各動脈,此即心臟收縮期的收縮和外排。因此,若心室供血異常,將導致身體組織失去血液之養分與氧量。The heart consists of two atria and two ventricles (Ventricle), in which the left ventricle receives arterial blood from the left atrium, which in turn supplies blood throughout the body. Under normal circumstances, the left ventricle myocardium can be instantaneously relaxed after each contraction, so that the blood from the pulmonary veins is quickly filled, which is the relaxation and filling of the diastolic phase; and rapid and intense contraction to push a large amount of blood into the aorta And transported to the body's arteries, which is the contraction and efflux of the systolic phase. Therefore, if the ventricle supply is abnormal, it will cause the body tissue to lose the nutrients and oxygen of the blood.
一般而言,心血管疾病之檢測僅能仰賴心電描記(Electrocardiography,ECG)及超音波檢測,這些儀器不僅昂貴且複雜,必需由醫護人員進行量測,事後之數據分析更需要經過專業訓練之人員才能判讀,因此病患一定要到醫院檢測而無法自行量測;因此,現有的檢測方式具有費時且不便之缺失。In general, the detection of cardiovascular disease can only rely on electrocardiography (ECG) and ultrasound detection. These instruments are not only expensive and complicated, but must be measured by medical personnel. After-the-fact data analysis requires professional training. The personnel can only be read, so the patient must go to the hospital for testing and cannot measure it by himself; therefore, the existing testing method is time-consuming and inconvenient.
為解決上述缺失,關業者紛紛開發不同裝置或方法,以期提供可隨身監控個人心血管健康情形,或用以預防或監控可能發生的心血管疾病以降低死亡率。舉例而言,中華民國專利公告第TW M486395 (U)號即揭示一種「多功能非侵入式智慧型心血管監測與診斷裝置」,其包括:一隨身主機,用以接收及分析資料,其上設有一顯示單元以及一輸入單元;一用以感測心血管相關診斷數值之感測裝置以及一用以儲存分析心血管相關診斷數值之資料上傳儲存分析裝置,係皆以有線或無線方式連接該隨身主機;藉此,可透過單機一次可檢驗心跳數、血氧濃度、身體不同部位血管硬化指數、血壓值、心律不整檢測及心脈診斷。然而,上述前案仍需於受測者之左右手甚至是腳設有電極感測器,以形成一無線式心電圖測量系統,並且測得之結果仍需經過人工智慧判斷以得知是否為心律不整。In order to address these shortcomings, the industry has developed different devices or methods to provide personal monitoring of cardiovascular health conditions or to prevent or monitor possible cardiovascular disease to reduce mortality. For example, the Republic of China Patent Bulletin No. TW M486395 (U) discloses a "multifunctional non-invasive intelligent cardiovascular monitoring and diagnostic device" comprising: a portable host for receiving and analyzing data thereon. a display unit and an input unit; a sensing device for sensing cardiovascular related diagnostic values; and a data uploading and storage analyzing device for storing and analyzing cardiovascular related diagnostic values, all connected by wire or wirelessly With the host; by this, you can check the heart rate, blood oxygen concentration, vascular sclerosis index, blood pressure value, arrhythmia detection and heart pulse diagnosis in different parts of the body. However, the above case still needs to be provided with an electrode sensor on the left and right hands or even the foot of the subject to form a wireless electrocardiogram measurement system, and the measured result still needs to be judged by artificial wisdom to know whether it is arrhythmia or not. .
另,中華民國專利公告第TW I336618 (B)號揭示一種「運用於健康管理裝置以同時實現生物認證與量測心律不整之偵測方法」,主要包括先擷取二維條碼影像,取得已註冊使用者之已註冊模版、特徵與醫師處方後儲存;比對使用者之即時心電圖與已註冊模版,若兩者之相關係數小於初步門檻值則以改良式跨零值法確認使用者是否發生致死型心律不整,發生則自動撥號求救;若相關係數大於初步門檻值,則表示該特定使用者無致死型心律不整。顯然,上述前案所或得的資料仍需經由醫護人員判讀,且偵測方法較為複雜。In addition, the Republic of China Patent Publication No. TW I336618 (B) discloses a "detection method for applying a health management device to simultaneously perform biometric authentication and measuring arrhythmia", which mainly includes first capturing a two-dimensional barcode image and obtaining a registered image. The user's registered template, features and physician's prescription are stored; compare the user's instant ECG with the registered template, if the correlation coefficient between the two is less than the initial threshold, confirm the user's death by the improved zero-crossing method. If the arrhythmia is irregular, it will automatically dial for help; if the correlation coefficient is greater than the initial threshold, it means that the specific user has no lethal arrhythmia. Obviously, the information obtained in the above case still needs to be interpreted by medical staff, and the detection method is more complicated.
今,發明人即是鑑於上述現有檢測心血管疾病之方法於實際實施使用時仍具有多處缺失,於是乃一本孜孜不倦之精神,並藉由其豐富專業知識及多年之實務經驗所輔佐,而加以改善,並據此研創出本發明。Now, the inventor is in view of the above-mentioned existing methods for detecting cardiovascular diseases, which still have multiple defects in actual implementation, so it is a tireless spirit, and with its rich professional knowledge and years of practical experience, Improvements have been made and the present invention has been developed based on this.
本發明主要目的為提供一種利用量測心臟血流脈波時間序列訊號以檢測心室供血異常之方法,其係指一種輔助檢查心血管疾病的測量方法,旨在將血壓計所量測的心血管供血脈波時間序列訊號經過轉換成對應之代表數值,而能快速檢測受測個體是否存在心室供血異常等心血管疾病。The main object of the present invention is to provide a method for measuring ventricular ventricular blood supply abnormality by measuring cardiac blood flow pulse time series signal, which is a method for assisting in the examination of cardiovascular diseases, and is intended to measure cardiovascular disease by a sphygmomanometer. The blood supply pulse time series signal is converted into a corresponding representative value, and can quickly detect whether the test subject has cardiovascular diseases such as abnormal ventricular blood supply.
為了達到上述實施目的,本發明一種量測心臟血流脈波時間序列訊號以檢測心室供血異常之方法,其步驟係包括:步驟一:於一受測者肱動脈量測一心血管供血脈波時間序列訊號之時間譜,以及每一心血管供血脈波時間序列訊號各個波峰構成的子波其相鄰子波之間隔值,記為A值;步驟二:計算心血管供血脈波時間序列訊號之時間譜的功率譜密度(power spectral density),同時將心血管供血脈波時間序列訊號的各個波峰構成的子波逐一計算功率譜密度,以取得每一心血管供血脈波時間序列訊號所具有之特性頻率(characteristic frequency)的能量密度值;步驟三:取心血管供血脈波時間序列訊號之時間譜的功率譜密度之最小頻率值,並由最小頻率值之倒數值做為B值;步驟四:將心血管供血脈波時間序列訊號的所有子波,逐一計算單一子波的功率譜密度,取每一子波最小頻率值之倒數值做為C值,以及第二小頻率值之倒數值做為D值; 以及步驟五:取心血管供血脈波時間序列訊號所有相鄰之波峰,亦即是相鄰子波之時間距離記為A值,A值之平均值記為<A>,其標準差記為E、取各個子波B值之平均值記為<B>,標準差記為EB,取各個子波C值之平均值記為<C>,標準差記為EC,取各個子波D值之平均值記為<D>,其標準差記為ED,由A、B、C、D、<A>、<B>、<C>、<D>以及E、EB、EC、ED值判別受測者是否心室供血異常。In order to achieve the above-mentioned implementation object, the present invention provides a method for measuring a blood flow pulse time series signal of a heart to detect abnormality of ventricular blood supply, and the steps thereof include: Step 1: measuring a cardiovascular blood supply pulse time in a radial artery of a subject The time spectrum of the sequence signal, and the interval between the adjacent wavelets of the wavelets formed by the respective peaks of each cardiovascular blood pulse time series signal, recorded as the A value; Step 2: Calculating the time of the cardiovascular blood supply pulse time series signal The power spectral density of the spectrum is calculated by simultaneously calculating the power spectral density of the wavelets composed of the respective peaks of the cardiovascular blood supply pulse time series signal to obtain the characteristic frequency of each cardiovascular blood pulse time series signal. Energy density value of (characteristic frequency); Step 3: taking the minimum frequency value of the power spectral density of the time spectrum of the cardiovascular blood supply pulse time series signal, and taking the inverse value of the minimum frequency value as the B value; Step 4: All wavelets of the cardiovascular blood supply pulse time series signal, calculate the power spectral density of a single wavelet one by one, and take each wavelet The reciprocal value of the minimum frequency value is taken as the C value, and the reciprocal value of the second small frequency value is taken as the D value; and the fifth step: taking all the adjacent peaks of the cardiovascular blood supply pulse time series signal, that is, the adjacent sub The time distance of the wave is recorded as the A value, the average value of the A value is recorded as <A>, the standard deviation is recorded as E, the average value of the B values of each wavelet is recorded as <B>, and the standard deviation is recorded as EB. The average value of the C value of the wavelet is recorded as <C>, and the standard deviation is recorded as EC. The average value of the D values of each wavelet is denoted as <D>, and the standard deviation is denoted by ED, and A, B, C, D, <A>, <B>, <C>, <D>, and E, EB, EC, and ED values discriminate whether the subject is abnormal in ventricular blood supply.
於本發明之一實施例中,步驟一心血管供血脈波時間序列訊號係利用一血壓監測設備量測,且心血管供血脈波之時間序列以及各波峰分別構成之子波訊號之採樣率係大於或等於180次/秒。In an embodiment of the present invention, the step 1 cardiovascular blood pulse time series signal is measured by a blood pressure monitoring device, and the time series of the cardiovascular blood supply pulse wave and the sampling rate of the wavelet signal formed by each peak are greater than or Equal to 180 times / sec.
於本發明之一實施例中,功率譜密度係利用離散傅立葉轉換(Discrete Fourier Transform)心血管供血脈波時間序列訊號之自相關函數(autocorrelation function)而得。In an embodiment of the present invention, the power spectral density is obtained by using an autocorrelation function of a discrete Fourier Transform cardiovascular blood vessel pulse time series signal.
於本發明之一實施例中,若A值或<A>值不在600-1200 ms範圍內、B值或<B>值不在30-100 ms範圍內、C值或<C>值不在100-300 ms範圍內、D值或<D>值大於200 ms,即判別受測者心室供血異常。In an embodiment of the present invention, if the A value or <A> value is not in the range of 600-1200 ms, the B value or <B> value is not in the range of 30-100 ms, and the C value or <C> value is not in the 100- Within 300 ms, the D value or <D> value is greater than 200 ms, which is to determine the abnormal blood supply to the ventricle of the subject.
於本發明之一實施例中,A值係連續2次心搏所需時間,亦即是每一心血管供血脈波時間序列訊號各個相鄰波峰之時間間隔值,或為心血管供血脈波時間序列訊號各個相鄰子波之時間間隔值;另,E值若大於A值或<A>值1/10以上,即判別受測者心室供血異常, EB值大於B值或<B>值1/10以上,EC值大於C值或<C>值1/10以上,或ED值大於D值或<D>值1/10以上,亦可判別受測者心室供血異常。In one embodiment of the present invention, the A value is the time required for two consecutive heart beats, that is, the time interval value of each adjacent peak of each cardiovascular blood pulse time series signal, or the cardiovascular blood supply pulse time. The time interval value of each adjacent wavelet of the sequence signal; if the E value is greater than the A value or the <A> value is more than 1/10, the ventricular blood supply abnormality is determined , and the EB value is greater than the B value or the <B> value 1 /10 or more, if the EC value is greater than the C value or the <C> value is 1/10 or more, or the ED value is greater than the D value or the <D> value is 1/10 or more, the ventricular blood supply abnormality of the subject can also be discriminated.
藉此,本發明之方法可快速判別受測個體是否心室供血異常,並且此方法輸出之結果為一數值而非複雜的訊號,因此無需醫護人員協助,受試者即可自行進行判讀。Thereby, the method of the invention can quickly determine whether the test subject has abnormal ventricular blood supply, and the result of the method output is a numerical value rather than a complicated signal, so the subject can perform the self-interpretation without the assistance of the medical staff.
本發明之目的及其結構功能上的優點,將依據以下圖面所示之結構,配合具體實施例予以說明,俾使審查委員能對本發明有更深入且具體之瞭解。The object of the present invention and its structural and functional advantages will be explained in conjunction with the specific embodiments according to the structure shown in the following drawings, so that the reviewing committee can have a more in-depth and specific understanding of the present invention.
請參閱第一圖,本發明一種利用量測心臟血流脈波之時間序列訊號以檢測心室供血異常之方法,其步驟係包括:Referring to the first figure, the present invention provides a method for measuring abnormality of ventricular blood supply by measuring a time series signal of a blood flow pulse of a heart, and the steps thereof include:
步驟一(S1):於一受測者肱動脈量測一心血管供血脈波時間序列訊號之時間譜,以及每一心血管供血脈波時間序列訊號相鄰子波對應波峰之間隔值為A值,其中A值係代表心血管供血脈波時間序列訊號各個子波相鄰波峰時間距離,亦即是每次心搏所需時間;較佳而言,心血管供血脈波時間序列訊號係利用一血壓監測設備量測,且心血管供血脈波時間序列訊號之採樣率係大於或等於180次/秒;Step 1 (S1): measuring the time spectrum of a cardiovascular blood supply pulse wave time series signal in a measured radial artery of the subject, and the interval value of the corresponding peak of the adjacent wavelet of each cardiovascular blood supply pulse time series signal is A value, The A value represents the time interval of the adjacent peaks of each wavelet in the cardiovascular blood supply pulse time series signal, that is, the time required for each heart beat; preferably, the cardiovascular blood supply pulse time series signal utilizes a blood pressure Monitoring device measurement, and the sampling rate of the cardiovascular blood pulse time series signal is greater than or equal to 180 times/second;
步驟二(S2):計算心血管供血脈波時間序列訊號之時間譜的功率譜密度(power spectral density),同時將心血管供血脈波時間序列訊號的各個波峰構成的子波逐一計算功率譜密度,以取得每一心血管供血脈波時間序列訊號所具有之特性頻率(characteristic frequency)的能量密度值;其中功率譜密度係利用離散傅立葉轉換(Discrete Fourier Transform) 心血管供血脈波時間序列訊號的自相關函數而得;由於訊號通常是波的形式表示,例如電磁波、隨機振動或者聲波,功率譜密度(PSD)即係以波的功率頻譜密度乘以一個適當的係數後所得到每單位頻率波攜帶的功率;Step 2 (S2): Calculate the power spectral density of the time spectrum of the cardiovascular blood supply pulse time series signal, and calculate the power spectral density one by one of the wavelets formed by the respective peaks of the cardiovascular blood supply pulse time series signal. To obtain the energy density value of the characteristic frequency of each cardiovascular blood pulse time series signal; wherein the power spectral density is determined by Discrete Fourier Transform, the cardiovascular blood supply pulse time series signal Correlation function; since the signal is usually a form representation of the wave, such as electromagnetic wave, random vibration or sound wave, the power spectral density (PSD) is carried by the power spectral density of the wave multiplied by an appropriate coefficient. Power
步驟三(S3):取心血管供血脈波時間序列訊號之時間譜的功率譜密度之最小頻率值,並由最小頻率值之倒數值做為B值;Step 3 (S3): taking the minimum frequency value of the power spectral density of the time spectrum of the cardiovascular blood supply pulse time series signal, and using the inverse value of the minimum frequency value as the B value;
步驟四(S4):將心血管供血脈波時間序列訊號的所有子波逐一計算單一子波的功率譜密度,由每一子波最小頻率值之倒數值做為C值,以及第二小頻率值之倒數值做為D值; 以及Step 4 (S4): Calculate the power spectral density of a single wavelet by calculating all the wavelets of the cardiovascular blood pulse time series signal one by one, the inverse value of the minimum frequency value of each wavelet as the C value, and the second small frequency The inverse value of the value is taken as the D value;
步驟五(S5):取各A、B、C與D值並計算每一心血管供血脈波時間序列訊號各個相鄰子波之A值之平均值記為<A>值和其標準差記為E值、分別計算各個子波的B值之平均值記為<B>值、C值之平均值記為<C>值,與D 值之平均值記為<D>值,並分別計算<B>、<C>與<D>之標準差記為EB值、EC值和ED值,由<A>、<B>、<C>、<D>以及E、EB、EC、ED值判別受測者是否心室供血異常;舉例而言,若A值或<A>值超出600-1200 ms、B值或<B>值超出30-100ms範圍、C值或<C>值超出100-300 ms範圍,或者D值或<D>值大於200 ms,即判別受測者心室供血異常,反之則正常;另,若E值大於A值或<A>值1/10以上,EB值大於B值或<B>值1/10以上,EC值大於C值或<C>值1/10以上,或ED值大於D值或<D>值1/10以上,亦可判別受測者心室供血異常。藉此,本案可就A、B、C、D或<A>、<B>、<C>、<D>,以及E、EB、EC、ED值之個別或結合其中任兩者以上,均可快速判定受測者心室供血是否存在異常情形。Step 5 (S5): Take the values of A, B, C and D and calculate the average value of the A values of each adjacent wavelet of each cardiovascular blood pulse time series signal as <A> value and its standard deviation is recorded as The E value and the average value of the B value of each wavelet are calculated as the <B> value, and the average value of the C value is recorded as the <C> value, and the average value of the D value is recorded as the <D> value, and is calculated separately. The standard deviations of B>, <C> and <D> are EB value, EC value and ED value, which are judged by <A>, <B>, <C>, <D> and E, EB, EC, ED values. Whether the subject has abnormal ventricular blood supply; for example, if the A value or <A> value exceeds 600-1200 ms, the B value or <B> value exceeds the range of 30-100 ms, the C value or <C> value exceeds 100-300 The ms range, or the D value or <D> value is greater than 200 ms, that is, the ventricle supply abnormality is judged by the subject, and vice versa. If the E value is greater than the A value or the <A> value is more than 1/10, the EB value is greater than B. The value or <B> value is 1/10 or more, and the EC value is greater than the C value or the <C> value is 1/10 or more, or the ED value is greater than the D value or the <D> value is 1/10 or more, and the ventricular blood supply of the subject can also be discriminated. abnormal. Therefore, the case may be any of A, B, C, D or <A>, <B>, <C>, <D>, and E, EB, EC, ED values, or a combination of two or more thereof. It can quickly determine whether there is abnormality in the blood supply to the ventricle of the subject.
此外,藉由下述具體實施例,可進一步證明本發明可實際應用之範圍,但不意欲以任何形式限制本發明之範圍。In addition, the scope of the invention may be further exemplified by the following specific examples, which are not intended to limit the scope of the invention.
首先,利用於一血壓監測設備進行量測6位受測者肱動脈之心血管供血脈波時間序列訊號,其原始脈波之時間序列訊號圖分別如第二、四、六、八、十、十二圖所示,採樣率係大於或等於180次/秒,以取得心血管供血脈波時間序列訊號之時間譜以及每一心血管供血脈波時間序列訊號對應波峰之間隔值為A值,這6位受測者為已知心室供血正常(編號1~3)與心室供血異常者(編號4~6)各3位。接著,將採集到的心血管供血脈波時間序列訊號之時間譜作一離散傅立葉轉換(Discrete Fourier Transform,DFT),並計算心血管供血脈波時間序列訊號之時間譜的功率譜密度(power spectral density)以取得每一心血管供血脈波時間序列訊號的能量密度值,取一最小頻率值,並由此最小頻率值之倒數值做為B值。Firstly, a blood pressure monitoring device is used to measure the cardiovascular blood supply pulse time series signals of the radial artery of the six subjects, and the time series signal diagrams of the original pulse waves are respectively as follows: second, fourth, sixth, eighth, ten, respectively. In the twelve figures, the sampling rate is greater than or equal to 180 times/second, in order to obtain the time spectrum of the cardiovascular blood supply pulse time series signal and the interval value of the corresponding peak of each cardiovascular blood pulse time series signal is A value, which is Six subjects were known to have normal ventricular blood supply (numbers 1 to 3) and ventricular abnormalities (numbers 4 to 6). Then, the time spectrum of the collected cardiovascular blood pulse time series signal is used as a discrete Fourier Transform (DFT), and the power spectral density of the time spectrum of the cardiovascular blood pulse time series signal is calculated (power spectral Density) to obtain the energy density value of each cardiovascular blood pulse time series signal, take a minimum frequency value, and thus the inverse value of the minimum frequency value as the B value.
接著,將心血管供血脈波時間序列訊號的所有單獨子波逐一計算功率譜密度,由每一子波最小頻率值之倒數值做為C值,以及第二小頻率值之倒數值做為D值;計取A值之統計平均值之標準差值為E值,由A、B、C、D以及E值判別受測者是否心室供血異常。所述A值可表示係相鄰2次心搏的間隔時間;B值之高低與心室功能健全與否有關;C值超出範圍代表心肌有缺血情形;D值可表示心臟房室傳遞所需的時間,當D值過高可能表示心肌短暫缺血,若D值呈現不穩定狀態,可能表示心臟房室傳遞受阻或為冠狀動脈粥狀硬化。上述各受測者之功率譜密度(PSD)頻譜圖分別如第三、五、七、九、十一、十三圖所示,每一圖式中之上圖為所有波鋒之PSD圖,下圖為單一波鋒之PSD示意圖。Next, the power spectral density is calculated one by one from all the individual wavelets of the cardiovascular blood pulse time series signal, and the inverse value of the minimum frequency value of each wavelet is taken as the C value, and the inverse value of the second small frequency value is taken as D. The standard deviation of the statistical mean of the A value is the E value, and the A, B, C, D, and E values are used to determine whether the subject has abnormal ventricular blood supply. The value of A may indicate the interval between two adjacent heart beats; the value of B is related to the sound function of the ventricle; the out-of-range value of C means that the myocardium has an ischemic condition; and the value of D may represent the requirement of cardiac atrioventricular transmission. Time, when the D value is too high may indicate transient myocardial ischemia, if the D value is unstable, it may indicate that the heart chamber transmission is blocked or coronary atherosclerosis. The power spectral density (PSD) spectrograms of the above-mentioned subjects are shown in the third, fifth, seventh, ninth, eleventh, and thirteenth graphs, respectively. The top graph in each graph is the PSD map of all wave fronts. The figure below shows the PSD of a single wave front.
請參閱第二圖~第十三圖,為本發明具體實施例中心室供血正常組(編號1~3)與心室供血異常組(編號4~6)之PSD頻譜圖,以及表一。PSD頻譜圖中的每一波峰即構成一子波,為心臟搏動一次所造成,由表一可知心室供血正常組(編號1~3)與心室供血異常組的E值和 A值;心室供血正常的受測者其「E值/<A>值」皆小於0.1;反觀心室供血異常的受測者其「E值/<A>值」則大於0.1。Please refer to the second to thirteenth figures, which are PSD spectrum diagrams of the central room blood supply normal group (No. 1~3) and the ventricular blood supply abnormal group (No. 4~6) according to the specific embodiment of the present invention, and Table 1. Each peak in the PSD spectrogram constitutes a wavelet, which is caused by the heart beat. Table 1 shows the E value and A value of the ventricular normal blood supply group (No. 1~3) and the ventricular blood supply abnormal group; the ventricular blood supply is normal. The "E value / <A> value" of the subjects was less than 0.1; the "E value / <A> value" of the subject with abnormal ventricular blood supply was greater than 0.1.
表一
本發明中所述固定之運算轉換式亦可內建並結合於血壓計,因此受測者將可藉由量測血壓時,判讀血壓計上的「E值/<A>值」是否超過0.1,即可隨時快速得知目前的心室供血是否正常。In the present invention, the fixed arithmetic conversion type can also be built in and combined with the sphygmomanometer, so that the subject can determine whether the "E value/<A> value" on the sphygmomanometer exceeds 0.1 by measuring the blood pressure. You can quickly find out if the current ventricular blood supply is normal.
另,請參閱表二,為本發明具體實施例中心室供血正常組(編號7~9)與心室供血異常組(編號10~12)之<A>、<C>和<D>值;由實際測量結果對比參照的正常範圍值,可知本案確實可由<A>、<C>和<D>值檢測判定受測者之心室供血是否正常。In addition, please refer to Table 2, which is the <A>, <C> and <D> values of the normal blood supply group (No. 7~9) and the ventricular blood supply abnormal group (No. 10~12) according to the specific embodiment of the present invention; The actual measurement results are compared with the normal range values of the reference. It can be seen that the case can be determined by the <A>, <C> and <D> values to determine whether the ventricle supply of the subject is normal.
表二:檢測心室供血正常與異常組之<A>、<C>和D>值
由上述之實施說明可知,本發明與現有技術相較之下,本發明具有以下優點:It can be seen from the above description that the present invention has the following advantages compared with the prior art:
1.本發明僅需由血壓計等進行手臂肱動脈之量測,不僅無須到醫療診所轉求專業人員協助,亦無需長時間貼置電極於皮膚進行心電描記,可提升個體對於其心血管健康情形監測之便利。1. The invention only needs to measure the brachial artery of the arm by a sphygmomanometer, etc., and it is not necessary to go to the medical clinic to seek professional assistance, and it is not necessary to place the electrode on the skin for electrocardiography for a long time, which can enhance the individual's cardiovascular disease. The convenience of monitoring health conditions.
2.本發明係已將對應於心電圖之複雜訊號,轉化為容易理解的數值(變異數)並進行計算,使受測個體得以自行快速得知是否有心室供血異常的情形發生。2. The present invention has converted the complex signal corresponding to the electrocardiogram into an easily understandable numerical value (variation number) and performs calculation so that the test subject can quickly know whether or not there is abnormal ventricular blood supply.
綜上所述,本發明之量測心臟血流脈波以檢測心室供血異常之方法,的確能藉由上述所揭露之實施例,達到所預期之使用功效,且本發明亦未曾公開於申請前,誠已完全符合專利法之規定與要求。爰依法提出發明專利之申請,懇請惠予審查,並賜准專利,則實感德便。In summary, the method for measuring blood flow pulse of the heart of the present invention to detect abnormal blood supply to the ventricle can achieve the intended use efficiency by the above disclosed embodiments, and the present invention has not been disclosed before the application. , Cheng has fully complied with the requirements and requirements of the Patent Law.爰Issuing an application for a patent for invention in accordance with the law, and asking for a review, and granting a patent, is truly sensible.
惟,上述所揭之圖示及說明,僅為本發明之較佳實施例,非為限定本發明之保護範圍;大凡熟悉該項技藝之人士,其所依本發明之特徵範疇,所作之其它等效變化或修飾,皆應視為不脫離本發明之設計範疇。The illustrations and descriptions of the present invention are merely preferred embodiments of the present invention, and are not intended to limit the scope of the present invention; those skilled in the art, which are characterized by the scope of the present invention, Equivalent variations or modifications are considered to be within the scope of the design of the invention.
(S1)‧‧‧步驟一(S1)‧‧‧Step one
(S2)‧‧‧步驟二(S2)‧‧‧Step 2
(S3)‧‧‧步驟三(S3) ‧ ‧ Step 3
(S4)‧‧‧步驟四(S4)‧‧‧Step four
(S5)‧‧‧步驟五(S5) ‧ ‧ step five
第一圖:本發明較佳實施例之步驟流程圖。First Figure: Flow chart of the steps of a preferred embodiment of the present invention.
第二圖:本發明其一正常組具體實施例之原始脈波之時間序列訊號圖。Second Figure: Time series signal diagram of the original pulse wave of a normal group embodiment of the present invention.
第三圖:本發明其一正常組具體實施例之PSD頻譜圖。Third Figure: PSD spectrum of a normal set of embodiments of the present invention.
第四圖:本發明其二正常組具體實施例之原始脈波之時間序列訊號圖。Fourth Figure: Time series signal diagram of the original pulse wave of the second normal group embodiment of the present invention.
第五圖:本發明其二正常組具體實施例之PSD頻譜圖。Fifth Figure: PSD spectrum diagram of a second normal embodiment of the present invention.
第六圖:本發明其三正常組具體實施例之原始脈波之時間序列訊號圖。Figure 6 is a time-series signal diagram of the original pulse wave of the third normal group embodiment of the present invention.
第七圖:本發明其三正常組具體實施例之PSD頻譜圖。Figure 7 is a PSD spectrum diagram of a third normal embodiment of the present invention.
第八圖:本發明其一心室供血異常組具體實施例之原始脈波之時間序列訊號圖。Figure 8 is a time-series signal diagram of the original pulse wave of a specific embodiment of the ventricular blood supply abnormality group of the present invention.
第九圖:本發明其一心室供血異常組具體實施例之PSD頻譜圖。Figure 9 is a PSD spectrum diagram of a specific embodiment of a ventricular blood supply abnormality group of the present invention.
第十圖:本發明其二心室供血異常組具體實施例之原始脈波之時間序列訊號圖。Fig. 10 is a time-series signal diagram of the original pulse wave of the specific embodiment of the two-ventricular blood supply abnormality group of the present invention.
第十一圖:本發明其二心室供血異常組具體實施例之PSD頻譜圖。Eleventh figure: PSD spectrum diagram of a specific embodiment of the two-ventricular blood supply abnormality group of the present invention.
第十二圖:本發明其三心室供血異常組具體實施例之原始脈波之時間序列訊號圖。Twelfth Figure: Time series signal diagram of the original pulse wave of the specific embodiment of the three-ventricular blood supply abnormality group of the present invention.
第十三圖:本發明其三心室供血異常組具體實施例之PSD頻譜圖。Fig. 13 is a PSD spectrum diagram of a specific embodiment of the three-ventricular blood supply abnormality group of the present invention.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW105136506A TWI604327B (en) | 2016-11-09 | 2016-11-09 | Method of detecting blood supply abnormality of ventricle by measuring arterial pulse wave |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW105136506A TWI604327B (en) | 2016-11-09 | 2016-11-09 | Method of detecting blood supply abnormality of ventricle by measuring arterial pulse wave |
Publications (2)
Publication Number | Publication Date |
---|---|
TWI604327B TWI604327B (en) | 2017-11-01 |
TW201818279A true TW201818279A (en) | 2018-05-16 |
Family
ID=61023098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW105136506A TWI604327B (en) | 2016-11-09 | 2016-11-09 | Method of detecting blood supply abnormality of ventricle by measuring arterial pulse wave |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI604327B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109616194A (en) * | 2018-10-22 | 2019-04-12 | 朱培永 | Human body information analytic method, device, program, storage medium and electronic equipment |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW273506B (en) * | 1993-01-07 | 1996-04-01 | Seiko Epson Corp | |
US6095984A (en) * | 1996-04-17 | 2000-08-01 | Seiko Epson Corporation | Arrhythmia detecting apparatus |
TW201635975A (en) * | 2015-04-13 | 2016-10-16 | 程深 | Method for determination on cardiovascular symptoms by use of hemopiezometer and causality algorithm spectrum |
-
2016
- 2016-11-09 TW TW105136506A patent/TWI604327B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TWI604327B (en) | 2017-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wong et al. | A comparative study of pulse rate variability and heart rate variability in healthy subjects | |
US10092268B2 (en) | Method and apparatus to monitor physiologic and biometric parameters using a non-invasive set of transducers | |
US20070021673A1 (en) | Method and system for cardiovascular system diagnosis | |
WO2011141765A1 (en) | Diagnostic classifications of pulse signal waveform data | |
US10561331B2 (en) | Method and apparatus for detecting atrial fibrillation | |
US10004473B2 (en) | Heart rate detection method and device using heart sound acquired from auscultation positions | |
TW201019898A (en) | Method and apparatus for presenting heart rate variability by sound and/or light | |
CN113160921A (en) | Construction method and application of digital human cardiovascular system based on hemodynamics | |
JP2006528023A (en) | Method and system for assessing cardiac ischemia based on heart rate variability | |
TWI604327B (en) | Method of detecting blood supply abnormality of ventricle by measuring arterial pulse wave | |
US20150157217A1 (en) | Analysis System for Cardiac Information and Analyzing Method Thereof | |
TWI702936B (en) | Pulse condition analysis method, prediction model establishment method and system based on acupoint resistance and blood pressure wave | |
TW200920316A (en) | Rapid method for analyzing bio-signal instantaneously by phase space difference and its device | |
Gargasas et al. | Development of methods for monitoring of electrocardiograms, impedance cardiograms and seismocardiograms | |
KR20230011773A (en) | Improved Quantification of Heart Rate Variability with \Multiscale Cumulative Residual Dispersion Entropy | |
US20160235314A1 (en) | Biosensor device, systems and methods thereof | |
TWM539909U (en) | Device for detecting abnormal blood supply for heart cavity | |
TW568768B (en) | Analysis method about relationship of beating signal and heart function | |
Wang et al. | Noninvasive cardiac output monitoring system based on photoplethysmography | |
JP2007252767A (en) | Blood oxygen concentration analyzer, and method and apparatus for measuring blood pressure value by electrocardiograph | |
Sopic et al. | Touch-based system for beat-to-beat impedance cardiogram acquisition and hemodynamic parameters estimation | |
TWI678187B (en) | Method for expressing characteristic points of heart beat and expressing physiological state of heart by using sequence diagram | |
CN106073750B (en) | Ventricular blood supply abnormality detection device and indirect collection processing method of heart pulse wave data | |
TWM551909U (en) | Apparatus for detecting atrial fibrillation | |
WO2012119665A1 (en) | Method and device for long-term variability monitoring of cardiovascular parameters based on ambulatory registration of electrocardiogram and pulse wave signals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |